| Name: | Apixaban Methyl Ester Impurity |
| Catalogue No. | VL3170007 |
| CAS No. | 1074365-84-6 |
| Molecular Formula | C26H26N4O5 |
| Molecular Weight | 474.51 |
| Status | In-stock |
| IUPAC Name | 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl) phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid methyl ester |
| Description | Apixaban Methyl Ester Impurity (CAS No: 1074365-84-6) or 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl) phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid methyl ester is a pyrazole derivative, it acts as Inhibition of factor Xa leads to decreased conversion of factor II to IIa, resulting in decreased thrombin generation and used in the treatment and prevent strokes or blood clots. |
| References | Hurst, Katherine, et al. “Quick Reference Guide to Apixaban.” Vascular Health and Risk Management, vol. Volume 13, July 2017, pp. 263–267, 10.2147/vhrm.s121944. |
